Globus Medical, Inc. (GMED) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Audubon, PA, United States. Der aktuelle CEO ist Keith W. Pfeil.
GMED hat IPO-Datum 2012-08-03, 5,300 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $12.84B.
Globus Medical, Inc. is a medical device company that develops and commercializes innovative healthcare solutions for patients with musculoskeletal disorders globally. The company offers a comprehensive portfolio of spine products, including traditional fusion implants, motion preservation technologies, interventional pain management solutions, and regenerative biologic products for treating degenerative conditions, deformities, tumors, and trauma. Additionally, Globus Medical provides orthopedic trauma solutions such as fracture plates and intramedullary nails, as well as hip and knee joint implants and related arthroplasty devices. The company also distributes human cell, tissue, and cellular and tissue-based products. Founded in 2003 and headquartered in Audubon, Pennsylvania, Globus Medical serves patients across the United States and international markets.
